Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals: A Retrospective Study and Review With Clinical Implications

NCT06550271 is registered in ClinicalTrials.gov with AgelessRx as lead sponsor.

NCT NCT06550271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06550271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Bioavailability of Compounded and Generic Rapamycin in Normative Aging Individuals: A Retrospective Study and Review With Clinical Implications
Lead sponsor
AgelessRx
Phase
Observational
Overall status
Completed
Start date
April 25, 2023
Completion date
December 15, 2023
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging